Cargando…

Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis

BACKGROUND: Pulse wave analysis (PWA) is a useful tool for non-invasive assessment of central cardiac measures as subendocardial perfusion (Subendocardial Viability Ratio, SEVR) or contractility (dP/dt(max)). The immediate influence of transcatheter aortic valve replacement (TAVR) on these indices h...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Claudia, Goliasch, Georg, Schachinger, Stefan, Kastl, Stefan, Neunteufl, Thomas, Delle-Karth, Georg, Kastner, Johannes, Gyöngyösi, Mariann, Lang, Irene, Gottsauner-Wolf, Michael, Pavo, Noemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248990/
https://www.ncbi.nlm.nih.gov/pubmed/30462701
http://dx.doi.org/10.1371/journal.pone.0207537
_version_ 1783372667612561408
author Müller, Claudia
Goliasch, Georg
Schachinger, Stefan
Kastl, Stefan
Neunteufl, Thomas
Delle-Karth, Georg
Kastner, Johannes
Gyöngyösi, Mariann
Lang, Irene
Gottsauner-Wolf, Michael
Pavo, Noemi
author_facet Müller, Claudia
Goliasch, Georg
Schachinger, Stefan
Kastl, Stefan
Neunteufl, Thomas
Delle-Karth, Georg
Kastner, Johannes
Gyöngyösi, Mariann
Lang, Irene
Gottsauner-Wolf, Michael
Pavo, Noemi
author_sort Müller, Claudia
collection PubMed
description BACKGROUND: Pulse wave analysis (PWA) is a useful tool for non-invasive assessment of central cardiac measures as subendocardial perfusion (Subendocardial Viability Ratio, SEVR) or contractility (dP/dt(max)). The immediate influence of transcatheter aortic valve replacement (TAVR) on these indices has not been investigated yet. METHODS: We prospectively enrolled 40 patients presenting with severe aortic stenosis receiving TAVR. Central pressure curves were derived from radial and carotid sites using PWA up to 2 days before and 7 days after TAVR. Parameters were compared between peripheral measurement sites. Changes in SEVR, dP/dt(max) and in indices of vascular stiffness were assessed. Additionally, association of these variables with clinical outcome was evaluated during a 12-month follow-up. RESULTS: Central waveform parameters were comparable between measurement sites. SEVR, but not dP/dt(max), augmentation Index (AIx) or augmentation pressure height (AGPH) correlated significantly with disease severity reflected by peak transvalvular velocity and mean transvalvular pressure gradient over the aortic valve (V(max), ΔPm) [r = -0.372,p = 0.029 for V(max) and r = -0.371,p = 0.021 for ΔPm]. V(max) decreased from 4.5m/s (IQR:4.1–5.0) to 2.2m/s (IQR:1.9–2.7), (p<0.001). This resulted in a significant increase in SEVR [135.3%(IQR:115.5–150.8) vs. 140.3%(IQR:123.0–172.5),p = 0.039] and dP/dt(max) [666mmHg(IQR:489–891) vs. 927mmHg(IQR:693–1092),p<0.001], and a reduction in AIx [154.8%(IQR:138.3–171.0) vs. 133.5%(IQR:128.3–151.8),p<0.001] and AGPH [34.1%(IQR:26.8–39.0) vs. 25.0%(IQR 21.8–33.7),p = 0.002], confirming the beneficial effects of replacing the stenotic valve. No association of these parameters could be revealed with outcome. CONCLUSIONS: PWA is suitable for assessing coronary microcirculation and contractility mirrored by SEVR and (max)dP/dt in the setting of aortic stenosis. PWA parameters attributed to vascular properties should be interpreted with caution.
format Online
Article
Text
id pubmed-6248990
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62489902018-12-06 Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis Müller, Claudia Goliasch, Georg Schachinger, Stefan Kastl, Stefan Neunteufl, Thomas Delle-Karth, Georg Kastner, Johannes Gyöngyösi, Mariann Lang, Irene Gottsauner-Wolf, Michael Pavo, Noemi PLoS One Research Article BACKGROUND: Pulse wave analysis (PWA) is a useful tool for non-invasive assessment of central cardiac measures as subendocardial perfusion (Subendocardial Viability Ratio, SEVR) or contractility (dP/dt(max)). The immediate influence of transcatheter aortic valve replacement (TAVR) on these indices has not been investigated yet. METHODS: We prospectively enrolled 40 patients presenting with severe aortic stenosis receiving TAVR. Central pressure curves were derived from radial and carotid sites using PWA up to 2 days before and 7 days after TAVR. Parameters were compared between peripheral measurement sites. Changes in SEVR, dP/dt(max) and in indices of vascular stiffness were assessed. Additionally, association of these variables with clinical outcome was evaluated during a 12-month follow-up. RESULTS: Central waveform parameters were comparable between measurement sites. SEVR, but not dP/dt(max), augmentation Index (AIx) or augmentation pressure height (AGPH) correlated significantly with disease severity reflected by peak transvalvular velocity and mean transvalvular pressure gradient over the aortic valve (V(max), ΔPm) [r = -0.372,p = 0.029 for V(max) and r = -0.371,p = 0.021 for ΔPm]. V(max) decreased from 4.5m/s (IQR:4.1–5.0) to 2.2m/s (IQR:1.9–2.7), (p<0.001). This resulted in a significant increase in SEVR [135.3%(IQR:115.5–150.8) vs. 140.3%(IQR:123.0–172.5),p = 0.039] and dP/dt(max) [666mmHg(IQR:489–891) vs. 927mmHg(IQR:693–1092),p<0.001], and a reduction in AIx [154.8%(IQR:138.3–171.0) vs. 133.5%(IQR:128.3–151.8),p<0.001] and AGPH [34.1%(IQR:26.8–39.0) vs. 25.0%(IQR 21.8–33.7),p = 0.002], confirming the beneficial effects of replacing the stenotic valve. No association of these parameters could be revealed with outcome. CONCLUSIONS: PWA is suitable for assessing coronary microcirculation and contractility mirrored by SEVR and (max)dP/dt in the setting of aortic stenosis. PWA parameters attributed to vascular properties should be interpreted with caution. Public Library of Science 2018-11-21 /pmc/articles/PMC6248990/ /pubmed/30462701 http://dx.doi.org/10.1371/journal.pone.0207537 Text en © 2018 Müller et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Müller, Claudia
Goliasch, Georg
Schachinger, Stefan
Kastl, Stefan
Neunteufl, Thomas
Delle-Karth, Georg
Kastner, Johannes
Gyöngyösi, Mariann
Lang, Irene
Gottsauner-Wolf, Michael
Pavo, Noemi
Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
title Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
title_full Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
title_fullStr Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
title_full_unstemmed Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
title_short Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
title_sort transcatheter aortic valve replacement (tavr) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248990/
https://www.ncbi.nlm.nih.gov/pubmed/30462701
http://dx.doi.org/10.1371/journal.pone.0207537
work_keys_str_mv AT mullerclaudia transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT goliaschgeorg transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT schachingerstefan transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT kastlstefan transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT neunteuflthomas transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT dellekarthgeorg transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT kastnerjohannes transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT gyongyosimariann transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT langirene transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT gottsaunerwolfmichael transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis
AT pavonoemi transcatheteraorticvalvereplacementtavrleadstoanincreaseinthesubendocardialviabilityratioassessedbypulsewaveanalysis